ArticlePloS one2026
Associations of dietary polyunsaturated fatty acids and sleep patterns with lung cancer in southwest China: A case-control study.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEvidence on the associations of polyunsaturated fatty acid (PUFA) intake and sleep patterns with lung cancer remains inconsistent. We aimed to examine these associations in southwest China and to explore whether the association between sleep patterns and lung cancer differed according to dietary PUFA intake.
methodsWe conducted a matched case-control study in Chongqing, southwest China, from August 22, 2023, to September 30, 2024. Each lung cancer case was matched to two controls by age group (<45, 45-65, or >65 years) and sex. Dietary PUFA intake was assessed using a validated semi-quantitative food frequency questionnaire (SQFFQ), and sleep patterns were evaluated using a composite healthy sleep score based on five sleep characteristics. Multivariable conditional logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs).
resultsA total of 322 lung cancer cases and 644 matched controls were included. In continuous analyses, each 1-g/day increase in omega-3 PUFA intake was associated with lower odds of lung cancer (OR = 0.82, 95% CI: 0.70-0.96). In tertile-based analyses, participants in the highest versus lowest intake tertiles had lower odds of lung cancer across all three PUFA types (omega-3 PUFAs: OR = 0.50, 95% CI: 0.32-0.78; omega-6 PUFAs: OR = 0.50, 95% CI: 0.31-0.80; total PUFAs: OR = 0.48, 95% CI: 0.30-0.79). Favorable sleep patterns were also associated with lower odds of lung cancer compared with unfavorable sleep patterns (OR = 0.59, 95% CI: 0.40-0.87). Although lower stratum-specific ORs were observed in the higher omega-3 PUFA intake stratum, the multiplicative interaction tests were not statistically significant.
conclusionHigher dietary omega-3 PUFA intake and favorable sleep patterns were each associated with lower odds of lung cancer in this matched case-control study. Associations for omega-6 and total PUFA intake were observed in tertile-based analyses but were not consistent across modeling approaches. These observational findings require confirmation in prospective studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.